My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
WORK PLANS
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
W
>
WASHINGTON
>
2560
>
2900 - Site Mitigation Program
>
PR0548313
>
WORK PLANS
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/23/2026 2:41:20 PM
Creation date
6/23/2026 2:19:12 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
WORK PLANS
RECORD_ID
PR0548313
PE
2960 - RWQCB LEAD AGENCY CLEAN UP SITE
FACILITY_ID
FA0027581
FACILITY_NAME
TESORO STOCKTON TERMINAL
STREET_NUMBER
2560
Direction
W
STREET_NAME
WASHINGTON
STREET_TYPE
ST
City
STOCKTON
Zip
95203
APN
14503012
CURRENT_STATUS
Active, billable
QC Status
Approved
Scanner
SJGOV\gmartinez
Supplemental fields
Site Address
2560 W WASHINGTON ST STOCKTON 95203
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
99
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
6.4.1 At least once per year, re-evaluate the spiking level. If more than 5% of the spiked samples do not <br /> return positive numerical results that meet all method qualitative identification criteria, then the spiking level <br /> must be increased and the initial MDL re-determined following the procedure in Section 6.1. <br /> 6.4.2 At least once every 13 months, re-calculate MDLS and MDLb using the equations in Section 6.2. Include <br /> data generated within the last 24 months, but only data from the same spiking level. A spreadsheet that <br /> collates each spiking level can be helpful for comparison. Documented instances of gross failures (e.g., <br /> instrument malfunctions, mislabeled samples, cracked vials) may be excluded from calculations. The <br /> rationale for removal of specific outliers shall be documented and maintained on file with the results of the <br /> MDL determination. If the laboratory believes the sensitivity of the method has changed significantly, then the <br /> data set used for calculations may be limited to the most recently collected data, while maintaining <br /> compliance with the requirement for at least seven replicates in three separate batches on three separate <br /> days (see Section 6.2.3). <br /> 6.4.3 Include the initial MDL spiked samples if they were analyzed within the last 24 months. <br /> 6.4.4 Only use data associated with acceptable calibrations and batch QC. <br /> 6.4.5 For MDLb calculations, include method blanks for all routine batches, with the exception of batches that <br /> are rejected and the associated samples reanalyzed. If the method has been altered in a way that can be <br /> reasonably expected to change its sensitivity, then only use data collected after the change. <br /> 6.4.6 Ideally, use all method blank results from the last 24 months for the MDLb calculation. The laboratory <br /> has the option to use only the last 6 months of method blank data or the 50 most recent method blanks, <br /> whichever criteria yields the greater number of method blanks. <br /> 6.4.7 The new calculated MDL is equal to the greater of the MDLS or MDLb. <br /> 6.4.8 If the new calculated MDL is within 0.5 to 2.0 times the existing MDL and fewer than 3% of the method <br /> blank results (for the individual analyte) have numerical results above the existing MDL, then the existing <br /> MDL may remain unchanged. If the new calculated MDL is not within 0.5 to 2.0 times the existing MDL or <br /> more than 3% of the method blank results (for the individual analyte) have numerical results above the <br /> existing MDL, then the new calculated MDL shall be used going forward. <br /> NOTE: The range of 0.5 to 2.0 approximates the 95th percentile confidence interval for the initial MDL <br /> determination with 6 degrees of freedom and is used to determine if the two values are statistically <br /> similar. <br /> 6.5) Determination of Initial MDL for a Specific Matrix <br /> 6.5.1 This section describes the determination of an MDL in a specific matrix other than a general quality <br /> systems matrix described in Section 5.3.1. <br /> 6.5.2 Analyze the sample matrix to determine the native (background) concentration of the analyte(s) of <br /> interest. <br /> 6.5.3 If the response for the native concentration is at a signal-to-noise ratio of N 5-20, determine the <br /> matrix-specific MDL according to Section 6.2, but without spiking additional analyte. Calculate MDLb <br /> according to Section 6.2.12, using method blanks, not the sample matrix. <br /> 6.5.4 If the response for the native concentration is at a signal-to-noise ratio is less than 5, then the <br /> analyte(s) should be spiked into the sample matrix to obtain a concentration that will give results with a <br /> signal-to-noise ratio of approximately 10-20. <br /> 6.5.5 If the analyte(s) of interest have signal-to-noise ratio(s) greater than —20, then the resulting MDL is <br /> likely to be biased high ' <br /> 6.6) Determination of the Limit of Quantitation (LOQ) <br /> 6.6.1 The LOQ shall be at or above the lowest corresponding calibration standard concentration, with the <br /> exception of methods using a single-point calibration, and must be greater than the MDL. <br /> 6.6.2 Each selected LOQ shall be verified through analysis of initial verification samples. An initial <br /> verification sample consists of spikes prepared and analyzed at concentrations at or below the selected LOQ. <br /> 6.6.3 All sample processing and analysis steps performed for routine sample analysis shall be included in the <br /> LOQ verification testing. <br /> 6.6.4 The LOQ shall have a signal-to-noise ratio of 6 or greater, twice the minimum for the MDL. <br />
The URL can be used to link to this page
Your browser does not support the video tag.